Jim Primerano joined WorldCare Clinical as Chief Executive Officer, bringing over 25 years of tech-enabled services leadership in life sciences, delivering value to pharmaceutical and biotechnology partners through high performing teams. Prior to serving as WorldCare Clinical’s CEO, Jim was Senior Vice President and General Manager at Signant Health, a leading clinical solutions provider. Jim also held a corporate strategy role at Medidata Solutions, responsible for driving organization growth through organic product expansion and operational excellence. Jim has a BA in Biology from the University of Pennsylvania and MBA from Rider University.
Andrew Kraus
Chief Operating Officer
Andrew Kraus joined WorldCare Clinical as Chief Operating Officer. He is a successful entrepreneur and accomplished executive within the international clinical trials industry with a strong track record of skillful management through the convergence of expertise in business strategy, operational excellence, technology innovation, and financial acumen. His leadership abilities have developed high performing international organizations, driving business transformation to increase profit margins and propel corporate growth. Andrew was previously GM & SVP at Signant Health, COO of the Medical Imaging & Technology Division at Bioclinica, and CTO at ICON Medical Imaging. Andrew has a BS and MS in Bioengineering from the University of Pennsylvania.
Ralph Reyes
Chief Financial Officer
Ralph Reyes is WorldCare Clinical’s Chief Financial Officer. Mr. Reyes served as Chief Operating Officer and Chief Financial Officer of Synarc, an imaging CRO. Mr. Reyes has almost 10 years of experience serving in both financial and operational roles at imaging core labs. Earlier in his career, Mr. Reyes led finance teams in the healthcare services industry at UnitedHealth Group and HealthNet. As a member of the company’s executive team, Mr. Reyes directs all aspects of the finance and accounting function. Mr. Reyes earned a B.A. in Economics from Amherst College.
Richard Walovitch
Chief Scientific Officer
Dr. Walovitch is Chief Scientific Officer of WCC, which he joined as Chief Medical Officer in January 2009. Prior to joining WCC, he served as the Senior Vice President of clinical research at Acusphere, Inc., Vice President of Preclinical and Clinical Research at Epix Medical, and held various positions as Research Pharmacologist and Project Clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a Doctorate in Pharmacology from the University of Illinois Medical Center and a Bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Jeff Schneebaum
Director of Operations, Ophthalmology
Jeff oversees the operations of the ophthalmic team at WorldCare Clinical. Jeff has served as Director of Operations at Digital Angiography Reading Center (DARC) for more than 13 years, helping to build the first all-digital ophthalmic reading center for clinical trials. Jeff has more than 20 years of experience working at Fortune 100 companies such as Credit Suisse First Boston and Colgate Palmolive. Jeff joined WCC in 2021 with the combination of DARC and WCC.
Jenny Borovac
Vice President, Engineering and Data Management
Jenny oversees the engineering and data management teams at WorldCare Clinical. Jenny has expertise in data monitoring and regulatory information management processes, gained from 15+ years in industry. Before joining WCC, Jenny was the manager of software services at Perkin Elmer, and prior to that she was responsible for the global team of data analysts, and imaging support specialists at PAREXEL.
Julianna Collins
Director, Business Development
Julianna Collins is an experienced clinical trial professional with over 12 years working medical imaging clinical trials. She has held various leadership roles in Project Management, Proposal Development, and Contracting. Additionally, before joining WCC Julianna held Project Management roles where she managed phase I-IV oncology, ophthalmology, and musculoskeletal studies as well as class I-III medical device trials. She is experienced in providing imaging core lab services in support of international trials while prioritizing quality, on-time data with high customer satisfaction.
Heather Flynn
Sr. Director Scientific Operations
Dr. Heather Flynn leads the Medical Research Science team at WCC. She has over 15 years of experience supporting drug development across various therapeutic areas including Oncology, Respiratory, Musculoskeletal, and Neurology. Before joining WCC, Heather held scientific and operational leadership roles within both CRO’s and the pharmaceutical industry. Heather completed her PhD in PET imaging of apoptosis and holds PRINCE2 certification.
Richard Walovitch, Ph. D.
Chief Scientific Officer
Dr. Walovitch is Chief Scientific Officer of WCC, which he joined as Chief Medical Officer in January 2009. Prior to joining WCC, he served as the Senior Vice President of clinical research at Acusphere, Inc., Vice President of Preclinical and Clinical Research at Epix Medical, and held various positions as Research Pharmacologist and Project Clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a Doctorate in Pharmacology from the University of Illinois Medical Center and a Bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Jason Slakter, M.D.
Medical Director
Dr. Slakter is an internationally recognized retinal disease specialist with over 30 years of experience in clinical practice. He created the Digital Angiography Reading Center (DARC), which is one of the largest centers for image evaluation for clinical trials of posterior segment disease with over 1,600 certified clinical sites in over 70 countries worldwide, serving as a key resource for industry-sponsored studies of new treatments for retinal disorders. Dr. Slakter is also a Clinical Professor of Ophthalmology at NYU School of Medicine and has published more than 100 papers and book chapters. Dr. Slakter serves as the Chief Executive Officer of Orphion Therapeutics, Inc., a gene therapy company focused on developing new treatments to meet unmet needs for rare genetic diseases. Dr. Slakter is WCC’s Medical Director for Ophthalmology and has worked with WCC since the combination of DARC and WCC in 2021.
Aaron Timm
Chief Executive Officer
Aaron Timm is CEO of WorldCare Clinical. Aaron joined WCC as CEO in November 2014 and has led the company’s successful growth and global expansion. Prior to joining WCC, he served as Chief Executive Officer of Synarc, an imaging CRO, from 2010 to 2014. Aaron joined Synarc as General Counsel in 2005. Earlier in his career, he worked as General Counsel of Vitria Technology, a publicly-traded software company. Aaron began his career practicing corporate law with Orrick, Herrington, & Sutcliffe LLP in San Francisco. He graduated summa cum laude from Georgetown University and with honors from Harvard Law School.
Matt Heggem
Vice President, Program Management
Matt Heggem oversees the progress and performance of key programs at WCC. He has over 17 years of experience supporting clinical trial programs in the imaging space across various therapeutic areas including Musculoskeletal, Immunology, Neurology, Cardiology, Orthopedics and Oncology. Before joining WCC, Matt held various leadership roles at Synarc and BioClinica, including most recent positions of Managing Director of Global Services and Director of Program & Project Management. To compliment his extensive program management experience, Matt has an MBA with a specialization in Project Management and holds PMP and PgMP certifications from the Project Management Institute.